Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | CRGY | CHH |
|---|---|---|
| Price | $13.56 | $99.58 |
| Change today | ▲ 1.27% | ▼ 2.85% |
| Market cap | $4.48B | $4.48B |
| Return, 3 months | +45.5% | -10.0% |
| Return, year to date | +66.4% | +5.7% |
| Return, 1 year | +54.3% | -3.1% |
| P/E (TTM) | 169.5 | 14.1 |
| P/B | 0.9 | 31.5 |
| P/E percentile vs own 5y | 99th | 10th |
| Dividend yield | 3.54% | 1.15% |
| Revenue growth (YoY, latest qtr) | – | +3.4% |
| Net profit growth (YoY) | – | -21.3% |
| Gross margin | – | 49.4% |
| Operating margin | – | 23.7% |
| Net margin | – | 14.6% |
| Return on equity | – | – |
| Analyst target vs. price | +32.7% | +14.2% |
| Analyst buy share | 83% | 20% |
| RSI (14) | 53 | 44 |
| 30-day volatility | 38.5% | 29.0% |
| Max drawdown, 1 year | -33.7% | -23.7% |
| Trend read | Leaning bullish | Strong downtrend |
| Analyst consensus | Buy | Hold |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
